Intouch Solutions

SEPTEMBER 27, 2024

From the increasing use of next generation sequencing based (NGS) tests in everyday clinical settings to groundbreaking research on tumor mutations that can help identify the most effective therapies, the promise of personalized cancer treatment is rapidly becoming a reality. And a lot of this biomarker research is fueled by AI.

DNA 59

DNA Trials Antibody Marketing 59

The Pharma Data

AUGUST 15, 2021

“WELIREG is the first and only approved systemic therapy for patients with certain types of VHL-associated tumors, representing an important new treatment option for patients affected by this rare condition,” said Dr. Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. months (range, 2.8 as assessed by IRC.

Hormones 52

Hormones Clinical Trials Clinical Trials Trials 52

FDA Law Blog

DECEMBER 11, 2023

Searches were done for all IVD panels: immunology, microbiology, clinical chemistry, pathology, toxicology, hematology, and molecular genetics. [15] See Jeff Shuren & William Maisel, Looking Ahead to 2022 as FDA’s Center for Devices and Radiological Health Manages a Sustained Increase in Workload , FDA Voices (Dec. 4] PRIA at 28.

In-Vitro 69

In-Vitro Regulation Production Development 69

pharmaphorum

AUGUST 10, 2020

Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The post Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ appeared first on.

Genetics 136

Genetics Genomics Genome Vaccine 136

The Pharma Data

NOVEMBER 26, 2020

Researchers studied the impact of cookstove pollutants on 23 people in Thanjavur, India, who use liquefied petroleum gas or wood biomass (wood, crop waste or wood brush) to cook. There may be a genetic predisposition for some individuals to be more susceptible to their environment, Kizhakke Puliyakote said. THURSDAY, Nov.

Development 52

Development Radiology Research Genetics 52

The Pharma Data

NOVEMBER 24, 2020

a postdoctoral researcher from the University of California San Diego School of Medicine. The researchers measured the concentrations of pollutants in the homes and then studied the lung function of the individuals, using traditional tests such as spirometry. OAK BROOK, Ill. , A multidisciplinary team led by Eric A. Hoffman , Ph.D.,

Radiology 52

Radiology Research Genetics Scientist 52

The Pharma Data

NOVEMBER 23, 2020

24, 2020 /PRNewswire/ — Anxiety is associated with an increased rate of progression from mild cognitive impairment to Alzheimer’s disease, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA). OAK BROOK, Ill. , Anxiety was measured with established clinical surveys.

Radiology 40

Radiology Genetics Research Scientist 40

XTalks

NOVEMBER 7, 2022

“Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace. cfDNA Isolation Techniques.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Delveinsight

DECEMBER 29, 2020

X-linked myotubular myopathy (XLMTM) is a rare genetic neuromuscular disorder and leads to muscle weakness, respiratory failure, and early death. The ASPIRO trial is a two-part, open-label ascending dose study, and is examining the safety and preliminary efficacy of AT132 in children with XLMTM younger than five years old. The post A USD 4.2

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

SEPTEMBER 11, 2024

Women encounter specific health issues that require specialized research and healthcare solutions, ranging from breast cancer to endometriosis. Despite advancements in medical research, women’s health has historically been underrepresented and underfunded, leading to disparities in treatment efficacy and safety for women.

Clinical Trials 103

Clinical Trials Clinical Trials Trials Hormones 103

Delveinsight

DECEMBER 10, 2020

That disparity that startled the researchers running the trials has been the topic of debate since AstraZeneca shared the top-line data. The two-dose efficacy figure covers divergent results between subjects who commenced on a half dose and those that got two full doses. The efficacy of the 2,741-subject half-dose primer arm was 90%.

Gene Therapy 52

Gene Therapy Gene Vaccine Vaccination 52

The Pharma Data

MARCH 24, 2021

It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. The Phase III D8110C00001 trial is part of this funding agreement. JPEO-CBRND.

Vaccination 52

Vaccination Vaccine Radiology Trials 52

The Pharma Data

MARCH 22, 2021

It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. The Phase III D8110C00001 trial is part of this funding agreement. JPEO-CBRND.

Trials 52

Trials Vaccination Vaccine Radiology 52

The Pharma Data

APRIL 7, 2023

3) Some lung cancers are linked to acquired genetic abnormalities. 5) Precision medicine is increasingly being developed for NSCLC patients with genetic changes, such as BRAF mutations, that can be detected using biomarker tests.(6,7) International Agency for Research on Cancer. Duration of response is a key secondary endpoint.

FDA Approval 40

FDA Approval Drugs Medicine Genetics 40

The Pharma Data

AUGUST 22, 2021

Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail. W911QY-21-9-0001. AstraZeneca is working with governments around the world to make AZD7442 accessible to high-risk populations as another valuable option in the fight to end COVID-19, should it prove to be effective and well tolerated.

Trials 52

Trials Antibody Vaccine Vaccination 52

The Pharma Data

NOVEMBER 20, 2020

. “Today’s authorization for a complete at-home test is a significant step toward FDA’s nationwide response to COVID-19,” Jeff Shuren, director of FDA’s Center for Devices and Radiological Health, said in a statement. Like PCR, the new test repeatedly copies genetic material until it reaches detectable levels.

Vaccine 52

Vaccine Vaccination Genetics Radiology 52

The Pharma Data

NOVEMBER 18, 2020

. “Today’s authorization for a complete at-home test is a significant step toward FDA’s nationwide response to COVID-19,” Jeff Shuren, director of FDA’s Center for Devices and Radiological Health, said in a statement. Like PCR, the new test repeatedly copies genetic material until it reaches detectable levels.

FDA Approval 52

FDA Approval Vaccination Vaccine Genetics 52

XTalks

SEPTEMBER 14, 2020

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. The Trump administration continues to pump money into vaccine research, this time shelling out $1.95 Drugs and Vaccines. COVID-19: Future and Predictions.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92